-
EP4126939
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4126939
| EP4126939 - ANTIBODIES THAT SPECIFICALLY BIND PEPTIDES ASSOCIATED WITH THE PRIMARY IMMUNODEFICIENCIES: WISKOTT-ALDRICH SYNDROME AND X-LINKED AGAMMAGLOBULINEMIA [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 06.01.2023 Database last updated on 09.09.2024 | |
| Former | The international publication has been made Status updated on 09.10.2021 | Most recent event Tooltip | 23.07.2024 | Supplementary search report | published on 21.08.2024 [2024/34] | Applicant(s) | For all designated states Seattle Children's Hospital d/b/a Seattle Children's Research Institute 4800 Sand Point Way NE Seattle, WA 98105 / US | [2023/06] | Inventor(s) | 01 /
HAHN, Sihoun 4800 Sand Point Way NE Seattle, Washington 98105 / US | 02 /
COLLINS, Christopher 4800 Sand Point Way NE Seattle, Washington 98105 / US | 03 /
YI, Fan 4800 Sand Point Way NE Seattle, Washington 98105 / US | 04 /
DAYUHA, Remwilyn 4800 Sand Point Way NE Seattle, Washington 98105 / US | [2023/06] | Representative(s) | Hobson, David James, et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | [2023/06] | Application number, filing date | 21780186.9 | 02.04.2021 | [2023/06] | WO2021US25627 | Priority number, date | US202063004415P | 02.04.2020 Original published format: US 202063004415 P | [2023/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2021203031 | Date: | 07.10.2021 | Language: | EN | [2021/40] | Type: | A2 Application without search report | No.: | EP4126939 | Date: | 08.02.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.10.2021 takes the place of the publication of the European patent application. | [2023/06] | Search report(s) | International search report - published on: | US | 11.11.2021 | (Supplementary) European search report - dispatched on: | EP | 22.07.2024 | Classification | IPC: | C07K16/18, A61K39/395, C12Q1/6883 | [2023/06] | CPC: |
G01N33/6848 (EP,US);
G01N33/6854 (EP,US);
C07K16/18 (EP);
C07K2317/34 (EP);
C12Q1/37 (EP);
G01N2333/4703 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/06] | Title | German: | ANTIKÖRPER, DIE SPEZIFISCH MIT DEN PRIMÄREN IMMUNDEFIZIENZEN ASSOZIIERTE PEPTIDE BINDEN: WISKOTT-CYSTEIN-SYNDROM UND X-VERKNÜPFTE AGAMMAGLOBULINÄMIE | [2023/06] | English: | ANTIBODIES THAT SPECIFICALLY BIND PEPTIDES ASSOCIATED WITH THE PRIMARY IMMUNODEFICIENCIES: WISKOTT-ALDRICH SYNDROME AND X-LINKED AGAMMAGLOBULINEMIA | [2023/06] | French: | ANTICORPS QUI SE LIENT SPÉCIFIQUEMENT À DES PEPTIDES ASSOCIÉS AUX IMMUNODÉFICIENCES PRIMAIRES : SYNDROME DE WISKOTT-ALDRICH ET AGAMMAGLOBULINÉMIE LIÉE À L'X | [2023/06] | Entry into regional phase | 02.11.2022 | National basic fee paid | 02.11.2022 | Search fee paid | 02.11.2022 | Designation fee(s) paid | 02.11.2022 | Examination fee paid | Examination procedure | 02.11.2022 | Examination requested [2023/06] | 04.05.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.02.2023 | Renewal fee patent year 03 | 26.02.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2012225060 (LEE SUM WAI PIERRE [US], et al); | [A]US2013302399 (FELDHAUS ANDREW LAWRENCE [US], et al); | [A]US2015322423 (KOSUGI AKIHIKO [JP], et al); | [A]US2018086846 (WILTZIUS JED [US], et al) |